Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quince Therapeutics, Inc.

1.06
-0.0400-3.64%
Volume:146.12K
Turnover:157.87K
Market Cap:46.64M
PE:-0.81
High:1.15
Open:1.12
Low:1.03
Close:1.10
Loading ...

Quince Therapeutics to Present at Citizens Life Sciences Conference

Business Wire
·
Yesterday

Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference

Business Wire
·
04 Apr

BRIEF-Quince Therapeutics Files For Common Stock Offering Of Up To $21.9 Million - SEC Filing

Reuters
·
25 Mar

Quince Therapeutics Files for Common Stock Offering of up to $21.9 Mln - SEC Filing

THOMSON REUTERS
·
25 Mar

BRIEF-Quince Therapeutics Existing Cash Position To Provide Operating Runway Through Phase 3 Topline Results Into 2026

Reuters
·
25 Mar

Quince Therapeutics: Existing Cash Position to Provide Operating Runway Through Phase 3 Topline Results Into 2026

THOMSON REUTERS
·
25 Mar

Press Release: Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results

Dow Jones
·
25 Mar

Quince Therapeutics Initiated at Outperform by Oppenheimer

Dow Jones
·
24 Mar

Oppenheimer Initiates Quince Therapeutics at Outperform

MT Newswires Live
·
24 Mar

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

Simply Wall St.
·
05 Mar

Quince Therapeutics: Gets Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia

THOMSON REUTERS
·
05 Feb

BRIEF-Quince Therapeutics Appoints William Whitehouse To Scientific Advisory Board

Reuters
·
24 Jan

Quince Therapeutics Appoints Renowned Pediatric Neurologist DR. William Whitehouse to Scientific Advisory Board

THOMSON REUTERS
·
24 Jan

Quince Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 Jan

Spotlight On US Penny Stocks For January 2025

Simply Wall St.
·
02 Jan

Quince Therapeutics Files Mixed Securities Shelf; Shares Rise After Hours

MT Newswires Live
·
19 Dec 2024

BRIEF-Quince Therapeutics Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing

Reuters
·
19 Dec 2024

Quince Therapeutics: Sales Agreement Prospectus Covers Offering of up to $75.0 Mln of Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
19 Dec 2024

Quince Therapeutics: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS
·
19 Dec 2024

Quince Therapeutics initiated with a Buy at Brookline

TIPRANKS
·
18 Dec 2024